| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 08/22/2002 | WO2002029411A3 Magnetic in situ dilution |
| 08/22/2002 | WO2002027326A3 Method and kit for the transderaml determination of analyte concentration in blood |
| 08/22/2002 | WO2002026107A3 Model for neurodegenerative diseases involving amyloid accumulation |
| 08/22/2002 | WO2002024221A3 Notch receptor agonists and uses |
| 08/22/2002 | WO2002024204A3 Treatment of diabetes mellitus by inhibition of mitochondrial calcium/sodium antiporter |
| 08/22/2002 | WO2002023186A3 System and method for optimizing drug therapy for the treatment of diseases |
| 08/22/2002 | WO2002010757A3 Diagnosis of liver cancer based on detecting sssa1 protein |
| 08/22/2002 | WO2002004918A3 Nanoporous membrane immunosensor |
| 08/22/2002 | WO2002003066A3 Quantitative fluorescent assay for determining the activity of transport proteins |
| 08/22/2002 | WO2002003061A3 Method for identifying substances which are suitable to be used for treating virus infections |
| 08/22/2002 | WO2002002773A3 Dual specificity antibodies and methods of making and using |
| 08/22/2002 | WO2001094944A3 Artificial antigen presenting cells and methods of use thereof |
| 08/22/2002 | WO2001081920A3 Comparative phenotype analysis for assessment of biologically active compounds |
| 08/22/2002 | WO2001075143A3 Sigma binding region of rna polymerase and uses thereof |
| 08/22/2002 | WO2001074903A3 Cd20/ige-receptor like molecules and uses thereof |
| 08/22/2002 | WO2001070982A3 Brca-1 regulators and methods of use |
| 08/22/2002 | WO2001068680A3 System and method for analysing active ingredients designed to influence intra-cellular processes |
| 08/22/2002 | WO2001060517A3 Container for nucleic acid analysis |
| 08/22/2002 | WO2000036393A3 Method and apparatus for automated reprocessing of tissue samples |
| 08/22/2002 | WO2000032239A9 Hapten-carrier conjugates for treating and preventing nicotine addiction |
| 08/22/2002 | WO2000026247A9 Ikaros isoforms and mutants |
| 08/22/2002 | WO2000023465A9 Methods and reagents for isolating biologically active peptides |
| 08/22/2002 | WO2000022411A9 Food viscometer and method of use |
| 08/22/2002 | WO2000014200A9 Essential bacterial genes and their use |
| 08/22/2002 | WO2000011195A9 C-myc is activated by beta-catenin and tcf-4 |
| 08/22/2002 | WO2000006771A9 Nucleic acid labeling compounds |
| 08/22/2002 | WO1999063992A9 Novel calcium channel drugs and uses |
| 08/22/2002 | US20020116726 Muir-torre-like syndrome in Fhit deficient mice |
| 08/22/2002 | US20020116724 Nucleotide sequences codingolypeptide for use in the diagnosis and prevention of psoriasis and venous ulcers |
| 08/22/2002 | US20020116155 Environmental monitoring system |
| 08/22/2002 | US20020116137 Method for detecting and measuring foam forming compounds in aqueous solutions |
| 08/22/2002 | US20020116135 Methods, systems, and articles of manufacture for evaluating biological data |
| 08/22/2002 | US20020115921 Screening test and procedure using skin patches |
| 08/22/2002 | US20020115862 Stable near-infrared (nir) marker dyes based on benzopyrylium-polymethines |
| 08/22/2002 | US20020115848 IBD-associated microbial nucleic acid molecules |
| 08/22/2002 | US20020115843 Nucleotide sequences for use in the treatment of viral diseases, hypertension and coagulation defects |
| 08/22/2002 | US20020115829 Pathogenic escherichia coli associated protein |
| 08/22/2002 | US20020115828 Nucleotide sequences for use in the detection of microorganismal infections |
| 08/22/2002 | US20020115724 Methods and agents for inhibiting protein aging |
| 08/22/2002 | US20020115722 Derivatives of 1-aryl-3-(2-chloroethyl)ureas having specific spatial configurations allowing these derivatives to dock inside cells at pre-selected sites. |
| 08/22/2002 | US20020115688 Screen for glutamate reuptake inhibitors, stimulators, and modulators |
| 08/22/2002 | US20020115631 Human bad polypeptides, encoding nucleic acids and methods of use |
| 08/22/2002 | US20020115627 Phosphatonin-related gene and methods of use thereof |
| 08/22/2002 | US20020115626 Comparing the expression of the nucleic acid encoding an antileuko-protease polypeptide of a cell population to the expression of a nucleic acid encoding the same peptide in an inflammation positive reference profile; enzyme inhibitors |
| 08/22/2002 | US20020115611 Determining the binding affinity of compounds for cloned gamma-aminobutyric acid (GABAA) receptors of alpha, beta and gamma subunits; cognitive activators; antianxiolytic agents; antidepressants; hypnosis; side effect reduction |
| 08/22/2002 | US20020115610 Isolated polypeptides that stimulate gastrointestinal smooth muscle contraction, including human; ionotropic agents; enhanced gastrointestinal motility; identifying a prokineticin receptor ligand; calcium mobilization |
| 08/22/2002 | US20020115607 Involved in the pathogenesis of Huntington's Disease, Parkinson's Disease, dementia and Alzheimer's Disease (AD); diagnosis, drug screening, animal models |
| 08/22/2002 | US20020115606 Involved in the pathogenesis of Huntington's Disease, Parkinson's Disease, dementia and Alzheimer's Disease (AD); modulating, in a cell, a protein complex between PN7740 and ligand Fe65 or PSD95 |
| 08/22/2002 | US20020115591 Gene yneS found in Streptococcus pneumoniae, which is essential for survival for a wide range of bacteria; use to identify antibiotics |
| 08/22/2002 | US20020115559 Biocatalytic and biomimetic generation of nitric oxide in situ at substrate/blood interfaces |
| 08/22/2002 | US20020115225 Microdevices for high-throughput screening of biomolecules |
| 08/22/2002 | US20020115223 In vitro system for determining formation of abeta amyloid |
| 08/22/2002 | US20020115222 Modified erythrocyte sedimentation rate |
| 08/22/2002 | US20020115217 Detecting modulators of cell metabolisms; obtain cells, incubate with modulator, monitor gene expression, detect adjusted metabolism in cells |
| 08/22/2002 | US20020115211 In vitro fertilization of human oocytes; obtain cells, incubate in nutrient broths, feterlize cells, propagate |
| 08/22/2002 | US20020115201 Microfluidic devices with monolithic microwave integrated circuits |
| 08/22/2002 | US20020115198 Microfabricated ultrasound array for use as resonant sensors |
| 08/22/2002 | US20020115187 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of arthritis and cancer; for use as antiscarring agent |
| 08/22/2002 | US20020115186 Peptide for use in the diagnosis, prevention, and treatment of inflammation, cancer, arteriosclerosis and degenerative defects |
| 08/22/2002 | US20020115183 Enzymatic protien for us ein prevention of tumor metastasis |
| 08/22/2002 | US20020115176 Polypeptide for use in the diagnosis and treatment of asthma, and respiratory disorders |
| 08/22/2002 | US20020115167 Isolation of drosophila and human polynucleotides encoding PAR-1 kinase, polypeptides encoded by the polynucleotides and methods utilizing the polynucleotides and polypeptides |
| 08/22/2002 | US20020115166 Peptide for use in the treatment of pancreatic defects |
| 08/22/2002 | US20020115157 Intrinsically fluorescent, self-multimerizing MHC fusion proteins and complexes thereof |
| 08/22/2002 | US20020115154 Trail receptors, nucleic acids encoding the same, and methods of use thereof |
| 08/22/2002 | US20020115151 Human defensin polypeptide Def-X, genomic DNA and cDNA, composition containing them and applications to diagnosis and to therapeutic treatment |
| 08/22/2002 | US20020115140 Nucleotide sequences coding preferential polypeptide for use in treatment of immmunological defects |
| 08/22/2002 | US20020115138 Nucleotide sequences coding transport protein for use in treat ment of tumors |
| 08/22/2002 | US20020115136 Peptide for use in the treatment, diagnosis and prevention of pancreatic disorders and grave's diease |
| 08/22/2002 | US20020115129 Screening the activity of drugs for central nervous system (CNS) |
| 08/22/2002 | US20020115127 MONITOR PROTEIN C ANTICOAGULATION; ACTIVATE COAGULATION CASCADE, TRIGGER COAGULATION, INCUBATE, MEASURE ACTIVITY OF EXOGENOUS SUBSTRATE, COMPARE TO CONTROL; Bioassay for qualitative and/or quantitative determination of functional activity of components of protein c anticoagulant pathway |
| 08/22/2002 | US20020115125 Radioimmunoassay testing kit for detecting aflatoxin-albumin adduct |
| 08/22/2002 | US20020115124 Agents that bind to and inhibit human cytochrome P450 2C19 |
| 08/22/2002 | US20020115123 Kit for the measurement of cyclic adenosine monophosphate |
| 08/22/2002 | US20020115122 Method and apparatus for automated assessment of the immunoregulatory status of the mononuclear leukocyte immune system |
| 08/22/2002 | US20020115121 Compositions and methods for detecting pre-cancerous conditions in cell and tissue samples using 5, 10, 15, 20-tetrakis (carboxyphenyl) porphine |
| 08/22/2002 | US20020115119 Protein-protein interactions in neurodegenerative diseases |
| 08/22/2002 | US20020115118 Multi-functional reagent for erythrocytes |
| 08/22/2002 | US20020115117 ERbeta-mediated gene expression |
| 08/22/2002 | US20020115116 Isolating preferential polypeptides from sample; obtain sample, express genes and generate fusion proteins, immobilize fusion protein, incubate with binding particle, recover bound particles |
| 08/22/2002 | US20020115114 Detecting modulators of kinase activity; obtain enzymatic polypeptide, incubate with modulator, monitor binding activity of kinases |
| 08/22/2002 | US20020115112 Neutrokine-alpha and Neutrokine-alpha splice variant |
| 08/22/2002 | US20020115110 Method of identifying agonist and antagonists for tumor necrosis related receptors TR1 and TR2 |
| 08/22/2002 | US20020115107 Pharmacophore recombination for the identification of small molecule drug lead compounds |
| 08/22/2002 | US20020115105 Measuring ligand binding to preferential receptors; form solution mixed with ligand and modultors, measure concentration of ligand, evaluate gene expression |
| 08/22/2002 | US20020115103 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use |
| 08/22/2002 | US20020115098 Detection of genetic agjustment in nucleotide sequences; obtain solid support, incubate with nucleotide sequence and probes, monitor signal from solid support |
| 08/22/2002 | US20020115096 Photo-induced electron transfer fluorescent sensor molecules |
| 08/22/2002 | US20020115094 Liver tumor marker sequences |
| 08/22/2002 | US20020115093 Combined polynucleotide sequences as discrete assay endpoints |
| 08/22/2002 | US20020115091 Compounds for use as tools in sequence analysis |
| 08/22/2002 | US20020115090 Expression analysis of KIAA nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| 08/22/2002 | US20020115088 Methods and probes for detection and/or quantification of nucleic acid sequences |
| 08/22/2002 | US20020115081 Nucleotide sequences coding polypeptide for use in the the treatament of cardiovasculAR disorders |
| 08/22/2002 | US20020115072 Probe bound substrate, process for manufacturing same, probe array, method of detecting target substance, method of specifying nucleotide sequence of single-stranded nucleic acid in sample, and quantitative determination of target substance in sample |
| 08/22/2002 | US20020115070 Methods and apparatus for analyzing gene expression data |
| 08/22/2002 | US20020115068 Matrix screening method |
| 08/22/2002 | US20020115067 Asymmetric benzoxanthene dye labelling reagents |
| 08/22/2002 | US20020115066 Detecting modulators which prevent viral infection; obtain lipid globule targeting sequence, incubate with modulator and globule, monitor adjustment in globule and binding protein activity |
| 08/22/2002 | US20020115064 Peptide or protein for use in the diagnosis, treatment or prophylaxis of viral disease |